Skip to main content

Nebula Research & Development LLC

SEC CIK
0001792635
Latest filing
May 15, 2026

AKRO holding history

Akero Therapeutics, Inc. in every 13F filed by Nebula Research & Development LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AKRO overviewAll 13F holders of AKROFull Q1 2026 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q2 2025
Holdings of AKRO by Nebula Research & Development LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−14,793−100.0%Sold outHolders
Q2 202514,793$789.4K0.1%+14,793NewHolders